In this article, three important clinical trials presented at the 2022 European Society of Cardiology Congress have been selected for a brief discussion. These are the SECURE, ADVOR and REVIVED-BCIS2 trials, all of which are investigator-initiated studies whose findings are of interest given their potential to impact clinical practice, ultimately improving current patient care and clinical outcomes.
Keywords: Clinical trials; acetazolamide; percutaneous coronary intervention; polypill.
Copyright © 2022, Radcliffe Cardiology.